|
|
||||||||
1 Department of Physiology, College of Medicine, University of Arizona, Tucson, Arizona 85724-5051; 2 Laboratory of Plasma Derivatives, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892
Two "blood
substitutes," a diaspirin cross-linked human hemoglobin [bis(3,5
dibromosalicyl)fumarate, DBBF-Hb] and a bovine polymerized hemoglobin
(PolyHbBv), advanced to clinical trials, are used in this study.
Previously, we have shown that injection of DBBF-Hb into the rat
circulation produces venular leakage and intestinal epithelial
disruption. The purpose of this study was to determine whether
PolyHbBv, currently approved for veterinary use in the United States,
shows similar effects. In anesthetized Sprague-Dawley rats, the
mesenteric microvasculature was perfused with DBBF-Hb
(n = 6), PolyHbBv (n = 5), cyanomet Hb
(CNmet-DBBF-Hb), or HEPES-buffered saline with 0.5% bovine serum
albumin (HBS-BSA) (controls, n = 7) for 10 min,
followed by FITC-albumin for 3 min, and then fixed for microscopy. For
DBBF-Hb, the mean leak number per micrometer venule length [2.41 ± 0.33 (±SE) × 10
3] was significantly greater
than for PolyHbBv (0.53 ± 0.14 × 10
3),
CNmet-DBBF-Hb (0.36 ± 0.14 × 10
3), and
HBS-BSA (0.12 ± 0.08 × 10
3)
(P < 0.01). Corresponding quantities for leak area
were 0.10 ± 0.03, 0.010 ± 0.003, 0.005 ± 0.003, and
0.02 ± 0.02 µm2/µm. In rats injected with
DBBF-Hb (n = 8), intestinal epithelial integrity was
significantly compromised compared with those injected with PolyHbBv
(n = 5) or saline (n = 6). These
results indicate that intravascular PolyHbBv produces significantly
less disruption of the intestinal exchange barrier than does DBBF-Hb,
probably because the heme is not so easily oxidized.
blood substitutes; fluorescence microscopy; venular leakage; electron microscopy
This article has been cited by other articles:
![]() |
A. G. Tsai, P. Cabrales, B. N. Manjula, S. A. Acharya, R. M. Winslow, and M. Intaglietta Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers Blood, November 15, 2006; 108(10): 3603 - 3610. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Dull, B. J. DeWitt, R. Dinavahi, L. Schwartz, C. Hubert, N. Pace, and C. Fronticelli Quantitative assessment of hemoglobin-induced endothelial barrier dysfunction J Appl Physiol, November 1, 2004; 97(5): 1930 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Baldwin, E. B. Wiley, and A. I. Alayash Differential effects of sodium selenite in reducing tissue damage caused by three hemoglobin-based oxygen carriers J Appl Physiol, March 1, 2004; 96(3): 893 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Baldwin, E. B. Wiley, A. G. Summers, and A. I. Alayash Sodium selenite reduces hemoglobin-induced venular leakage in the rat mesentery Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H81 - H91. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |